. Also, it has been shown to inhibit peptide secretion in patients with functioning endocrine tumors [lo-121. However, octreotide (SMS) does not effectively inhibit the growth of cells in insulinomas, despite it being a well-established antigrowth peptide.
Transmembrane signal (hormone, growth factor, etc.) receptors are associated with a class of proteins bound to the cytoplasmic side of the cell membrane which bind to guanine nucleotides such as guanosine triphosphate (GTP) with high affinity [13] . These membrane-bound cytoplasmic guanine nucleotide-binding proteins, called G proteins [14, 151, are supplemented with 5% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 1% penicillin, and 1% streptomycin and were allowed to grow to confluence before beginning each experimental protocol. In preparation for each experiment, cells were detached using 0.05% trypsin-0.53% mM NaEDTA in Hank's balanced salt solution and subsequently were plated onto 5 wells in 6-well tissue culture plates and grown in 2 ml medium supplemented with 1% fetal bovine serum X 48 hr. This was followed by 2 ml of standard media (RPMI-1640 with 2 mM L-glutamine, 1% penicillin, and 1% streptomycin) supplemented with 0.5% fetal bovine serum X 24 hr. The medium was aspirated and 2 ml fresh medium was added at the start of all test conditions.
The viability of cells was tested by trypan blue exclusion tests. These tests showed >90% viable cells throughout all stages of these experiments.
Treatment with Pertussis Toxin
RINm5F cells were pretreated with pertussis toxin (PT) (100 rig/ml) for 4 hr. Studies in which RINm5F cells were preincubated with concentrations of PT ranging from 50 to 400 rig/ml produced results that were similar to those obtained with 100 rig/ml for a 4-hr pretreatment. The wells containing PT were aspirated, replaced with 2 ml medium, and the respective additive dosages of octreotide were used for each test condition. counter. The cell pellet was treated with 3% perchloric acid (PCA), heated at 95°C for 10 min, iced for 20 min, and then centrifuged at 2900 rpm for 10 min. Supernatant was used to measure DNA by direct assay.
DNA Assay
Two hundred and fifty microliters of 3% perchloric acid was added to assay tubes. DNA standard was prepared using 0.3 mg/ml DNA (calf thymus, Sigma) in 5 mM NaOH diluted 1:l in 1 N perchloric acid, heated to 70°C for 15 min.
A DNA standard curve was used to estimate unknown values. One milliliter of diphenylamine reagent was added to a total volume of 500-~1 samples and incubated at 30°C for 6-24 hr. Samples were read at 600 nm on a spectrophotometer (Hitachi, Model 100-40). Results for tritiated thymidine incorporation into extracted DNA were calculated and expressed as counts per minute per microgram of DNA.
Insulin
To study the effects of octreotide on insulin secretion, conditioned media were sampled after 24 hr with and without octreotide. Replicates ~5 were used in each experiment.
Results are expressed as mean + SEM (N > 3).
Immunoreactive insulin was measured by using a double-antibody radioimmunoassay with an lz51-porcine insulin tracer, a rat insulin standard (Novo), a guinea pig anti-rat insulin first antibody (Linco Research), and a sheep anti-guinea pig gamma globulin-PEG second antibody. Limit of sensitivity for the assay was 3 pU/ml. Interassay and intraassay coefficients of variability were 3.2 and 1.4%, respectively. Cyclic Adenosine Monophosphate (CAMP) Intracellular CAMP was measured following incubation with octreotide for 15 min. Cold 6% TCA (1 ml) was added to wells, and cells were scraped off using a rubber policeman.
Fragments and TCA were collected and placed into tubes (5 wells/tube) and centrifuged at 1800 rpm for 20 min. The supernatant was washed in 4 X 4 ml with diethyl ether (saturated with water), and 200 ml from the aqueous layer was assayed for immunoreactive CAMP.
A for greater sensitivity. Limit of sensitivity is 17.8 fmole/ ml. Interassay and intraassay coefficients of variability are 5.4 and 1.5%, respectively. Statistics 9, 231. In contrast to these studies, there was no significant inhibition in cell numbers with increasing concentrations of octreotide (50-5000 nM) in the RINm5F cell (shown in Fig. 1) . Similarly, there were no significant changes in protein content observed in RINm5F cells incubated in the presence of the same range of dosages of octreotide (Table 1 ).
Significant differences between treatment groups were tested for using the Wilcoxon rank sign test and the Student t test. A P value < 0.05 was the criterion used to identify a significant difference.
RESULTS
To further study the observed lack of effect of octreotide on RINm5F cell number, we examined the effect of octreotide on tritiated thymidine incorporation into the extracted DNA of these cells. Increasing concentrations of octreotide (50-5000 nM) had no significant effect on the extent of tritiated thymidine incorporation into extracted DNA (TTID) in RINm5F cells incubated in the presence of standard media supplemented with 1% fetal bovine serum (shown in Fig. 2 ). grown under previously described experimental conditions in response to SMS (50 nM) (see Table 2 ).
Effect of Octreotide on Cell Number and

Effect of Octreotide on TTID after Pretreatment with Pertussis Toxin
Pretreatment with pertussis toxin is known to disrupt the inhibitory alpha subunit of the guanine nucleotidebinding regulatory component (GJ by ADP-ribosylation and thereby block the inhibitory effect of SMS on the adenylate cyclase system. In these experiments, octreotide alone did not inhibit tritiated thymidine incorporation into extracted DNA; however, octreotide significantly inhibited tritiated thymidine incorporation into extracted DNA in RINm5F cells pretreated with pertussis toxin (100 rig/ml/4 hr) (23553 + 1747 vs 20635 [cpm/ pg DNA] + 1983 [SEMI, P < 0.01) (shown in Fig. 3) . Similar results were observed even after pretreatment with 400 rig/ml/4 hr of pertussis toxin (data not shown). In addition, octreotide also inhibited insulin secretion into condition media from 47 f 4.0 to 40 & 4.2 (pU/ml * SEM) in RINm5F cells pretreated with 50 rig/ml of pertussis toxin.
DISCUSSION
Somatostatin or its analogue is known to be a potent antisecretory and antigrowth peptide [31] . However, the exact mechanism(s) for its antigrowth effects are unknown. There are several fundamental mechanisms by which cell growth in endocrine cells may become abnormal. These mechanisms include abnormalities of growth factor production, abnormalities of growth factor receptors, reduced production of growth-inhibitory regulatory factors, or disturbances of post-receptor signal transduction [32] . Somatostatin may play a role in one or more of these fundamental mechanisms controlling abnormal (neoplastic) growth in any given cell. Somatostatin was initially isolated based on its ability to inhibit growth hormone secretion from rat anterior pituitary cells in culture [l] . Subsequently, it has been shown to inhibit the secretion of several other hormones by pituitary cells in culture [33] . Furthermore, it has been shown that somatostatin inhibits such hormonal secretion by attenuating the formation of intracellular cyclic AMP [34, 351. Our data demonstrating that octreotide inhibits insulin secretion and intracellular cyclic AMP levels in RINm5F cells are consistent with these reported observations.
Human studies using octreotide in the treatment of patients with malignant insulinomas have shown that octreotide does not reduce the size or inhibit the growth of the tumor, but that it does reduce the levels of circulating insulin (IRI) in such patients [36-381. Our in vitro studies using a rat insulinoma cell line, RINm5F, also showed that increasing concentrations of octreotide did not reduce or inhibit the proliferation of cells, but it did reduce the levels of immunoreactive insulin secreted into the conditioned media (see Figs. 1 and 2, Table 2 ). In addition, we did not observe any significant changes in the protein content of these cells following treatment with octreotide. The parallel patterns of response of RINm5F cells in culture to those observed for human insulinomas suggest that our experimental model using RINm5F cells in vitro is a functional and useful model with which to investigate the mechanisms of peptide action in insulinomas.
Pertussis toxin is known to ADP-ribosylate the inhibitory alpha subunit of the membrane-bound guanine nucleotide binding protein, Gi. Somatostatin is known to mediate several of its postreceptor effects via the membrane-bound inhibitory subunit of guanine nucleotide binding protein (Gi). Furthermore, it has been shown that the inhibitory effects of somatostatin can be blocked by pretreatment with pertussis toxin [18, 23, 24, 391. In these experiments, pertussis toxin pretreatment followed by treatment with octreotide resulted in a significant inhibition of tritiated thymidine incorporation into the extracted DNA of RINm5F cells. The mechanism for this net inhibitory effect of octreotide in RINm5F cells only after pretreatment with pertussis toxin is unclear. It is possible that octreotide exerts both stimulatory and inhibitory effects on cell proliferation in RINm5F cells and that the stimulatory effects are pertussis toxin-sensitive. Alternatively, Gi in the RINm5F cell may be altered, expressed differently, or associated with an abnormal or a different signal transducting mechanism in these cells. Consequently, pertussis toxin may exert a net activation of Gi in the RINm5F cell.
Alteration of G, in disease states is not without prece-
